India's Wockhardt rises on antibiotic drug's clinical study results

Wockhardt

13/01/2025 06:08

** Shares of India's Wockhardt Ltd  WCKH.NS  rise as much as
3.9% to 1,442 rupees
    ** Pharma co says its antibiotic drug Zaynich, which targets
multi-drug-resistant, gram-negative infections, achieved over
97% efficacy in clinical study for serious infections
    ** Stock on track to snap three days of losses
    ** WCKH gained 233.9% in 2024, its second straight year of
gains

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))